DUBLIN--(BUSINESS WIRE)--The "Global
Iron Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's
The Global Iron Drugs Market is expected to grow at a CAGR of 9.27% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend affecting this market is the growing focus on the emerging economies. Several vendors are focusing on emerging economies due to the opportunities for growth. This is because the prevalence of CKD and other diseases such as CHF is increasing in emerging economies such as India, China, and Brazil.
According to the report, one driver influencing this market is the presence of large patient pool with various disorders. The demand for iron drugs is increasing due to the presence of a large patient pool with various disorders. Some risk factors of iron deficiency include CKD, non-dialysis CKD, congestive heart failure (CHF), and postpartum anaemia. The presence of large patient pool with various disorders will drive the growth of the global iron drugs market during the forecast period.
Further, the report states that one challenge affecting this market is the high cost of drugs. The high cost of IV iron drugs is a challenge for the growth of the global iron drugs market. Though IV iron drugs are associated with many advantages over oral iron drugs, they are expensive than oral iron drugs.
- AMAG Pharmaceuticals
- Daiichi Sankyo
- Vifor Pharma
Key Topics Covered
1. Executive Summary
2. Scope of the Report
3. Research Methodology
4. Market Landscape
5. Market Sizing
6. Five Forces Analysis
7. Market Segmentation by Product
8. Customer Landscape
9. Regional Landscape
10. Decision Framework
11. Drivers and Challenges
12. Market Trends
13. Vendor Landscape
14. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/wf2789/global_iron_drugs?w=4